Related Experiment Video
Updated: Feb 6, 2026

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to
Yanina Galboiz1, Sarah Shapiro, Nitza Lahat
1Neuroimmunology Unit, Department of Neurology, Carmel Medical Center, 7 Michal Street, Haifa, Israel.
Abstract:
Recent findings have implicated the activity of matrix metalloproteinases (MMPs) in the pathogenesis of multiple sclerosis (MS), while in vivo interferon (IFN)-beta treatment was demonstrated to suppress MMPs. In the present study, the effects mediated by IFN-gamma and IFN-beta on the mRNA and protein expression of MMP-2, its physiological activator, MT1-MMP and its endogenous inhibitor, TIMP-2, by monocytes were evaluated in vitro. The results point to the significance of IFNs in modulating MMPs/tissue inhibitors of MMPs (TIMPs) expression, and support the possibility that the therapeutic effects of IFN-beta may be, in part, due to induction of a shift from "pro-" to "anti-proteolytic" pattern of MMPs and TIMPs expression.
Insights
Interferons (IFNs) modulate matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) in monocytes. This suggests interferon-beta
Area of Science:
- Neuroimmunology
- Molecular biology
- Cell biology
Background:
- Matrix metalloproteinases (MMPs) are implicated in multiple sclerosis (MS) pathogenesis.
- Interferon-beta (IFN-beta) treatment in vivo suppresses MMPs.
- Monocytes play a role in the inflammatory processes of MS.
Purpose of the Study:
- To investigate the in vitro effects of interferon-gamma (IFN-gamma) and interferon-beta (IFN-beta) on MMP-2, MT1-MMP, and TIMP-2 expression in monocytes.
- To understand the role of IFNs in regulating the proteolytic balance in monocytes relevant to MS.
Main Methods:
- In vitro study using human monocytes.
- Evaluation of mRNA and protein expression levels.
- Analysis of MMP-2, MT1-MMP (MMP activator), and TIMP-2 (MMP inhibitor) expression.
- Treatment with IFN-gamma and IFN-beta.
Main Results:
- Both IFN-gamma and IFN-beta significantly modulated the expression of MMP-2, MT1-MMP, and TIMP-2 in monocytes.
- IFNs induced changes in both mRNA and protein levels of these key molecules.
- A shift in the expression pattern towards an anti-proteolytic profile was observed.
Conclusions:
- Interferons play a crucial role in regulating the expression of MMPs and TIMPs in monocytes.
- The therapeutic effects of IFN-beta in MS may be partly attributed to its ability to induce an anti-proteolytic shift.
- These findings highlight the potential of targeting MMP/TIMP pathways in MS treatment.
Related Concept Videos
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
2° Amines to N-Nitrosamines: Reaction with NaNO2
SN2 Reaction: Kinetics
In a chemical reaction, a relationship exists between the concentration of reactants and the rate at which the reaction proceeds. The study to measure this relationship is known as the kinetics of a chemical reaction. Kinetic studies are used to deduce the rate law of a chemical reaction, which provides information about the species involved during the transition state of the rate-determining step. Thus, kinetic studies help to derive the mechanism of a...
SN2 Reaction: Mechanism
The presence of the more electronegative halogen in the substrate creates a polarized carbon-halide bond. The halide pulls the electron cloud generating an electrophilic center at the carbon atom. Thus, the carbon atom carries a partial positive charge while the halide has a...
SN2 Reaction: Transition State
When the nucleophile approaches the electrophilic carbon with its lone pairs, the halide acts as a leaving group and moves away with the electron-pair bonded to the carbon. Dotted partial bonds represent the bonds being formed or broken...
SN2 Reaction: Stereochemistry
If the substrate is an achiral molecule at the α-carbon, the inversion of configuration is not...

